Q2 2020 Holdings
Filed 2020-08-12 | 11 holdings | $1.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Autolus Therapeutics Limited(AUTL) | Common | 05280R100 | $637.0K | 39,740 | 62.9% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $74.1K | 2,388,337 | 7.3% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $64.7K | 3,898,422 | 6.4% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $51.8K | 3,370,982 | 5.1% |
| MEI Pharma, Inc. | Common | 552798202 | $41.9K | 10,137,859 | 4.1% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $37.4K | 2,331,534 | 3.7% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $34.5K | 1,423,794 | 3.4% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $25.3K | 539,648 | 2.5% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $19.9K | 308,686 | 2.0% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $14.6K | 337,291 | 1.4% |
| Merus N.V. | Common | N5749R100 | $11.3K | 700,879 | 1.1% |